Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.

Our previous study showed that proMMP-9 was activated by MMP-3 directly, and that proMMP-3 was activated by plasmin. It was postulated that the proMMP-9 activation mechanism through the protease-protease cascade existed even in vivo. The purpose of the present study was to clarify the clinical signi...

Full description

Bibliographic Details
Main Authors: Inuzuka, K, Ogata, Y, Nagase, H, Shirouzu, K
Format: Journal article
Language:English
Published: 2000
_version_ 1826275235480993792
author Inuzuka, K
Ogata, Y
Nagase, H
Shirouzu, K
author_facet Inuzuka, K
Ogata, Y
Nagase, H
Shirouzu, K
author_sort Inuzuka, K
collection OXFORD
description Our previous study showed that proMMP-9 was activated by MMP-3 directly, and that proMMP-3 was activated by plasmin. It was postulated that the proMMP-9 activation mechanism through the protease-protease cascade existed even in vivo. The purpose of the present study was to clarify the clinical significance of the combined expression of MMP-9, MMP-3, and urokinase-type plasminogen activator (uPA) in colorectal cancer, and the role of MMP-3 or uPA expression as an activator for MMP-9. The expression of both MMP-9 and uPA was found to be correlated with liver metastasis, and with survival rate. The coexpression of MMP-9 and uPA by tumor cells was also significantly correlated with postoperative hepatic recurrence and survival rate. MMP-9 tended to be coexpressed with uPA, and was consistently associated with MMP-3 localized at the tumor-invasive front with inflammatory cells such as monocyte-macrophages. In gelatin zymography, the MMP-9 active form tended to be identified in the tumors that coexpressed both MMP-9 and uPA. We concluded that coexpression of MMP-9 and uPA in tumor tissues might be a useful predictive factor for postoperative survival and hepatic metastasis. The following activation mechanism for proteinase might occur: uPA coexpressed with MMP-9 activated plasminogen, and plasmin activated proMMP-3, which was secreted depending upon inflammatory infiltration, and then MMP-3 activated proMMP-9, resulting in colorectal cancer progression and metastasis.
first_indexed 2024-03-06T22:55:37Z
format Journal article
id oxford-uuid:6042e903-06ca-4c93-9e1b-e47eac47281a
institution University of Oxford
language English
last_indexed 2024-03-06T22:55:37Z
publishDate 2000
record_format dspace
spelling oxford-uuid:6042e903-06ca-4c93-9e1b-e47eac47281a2022-03-26T17:52:21ZSignificance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6042e903-06ca-4c93-9e1b-e47eac47281aEnglishSymplectic Elements at Oxford2000Inuzuka, KOgata, YNagase, HShirouzu, KOur previous study showed that proMMP-9 was activated by MMP-3 directly, and that proMMP-3 was activated by plasmin. It was postulated that the proMMP-9 activation mechanism through the protease-protease cascade existed even in vivo. The purpose of the present study was to clarify the clinical significance of the combined expression of MMP-9, MMP-3, and urokinase-type plasminogen activator (uPA) in colorectal cancer, and the role of MMP-3 or uPA expression as an activator for MMP-9. The expression of both MMP-9 and uPA was found to be correlated with liver metastasis, and with survival rate. The coexpression of MMP-9 and uPA by tumor cells was also significantly correlated with postoperative hepatic recurrence and survival rate. MMP-9 tended to be coexpressed with uPA, and was consistently associated with MMP-3 localized at the tumor-invasive front with inflammatory cells such as monocyte-macrophages. In gelatin zymography, the MMP-9 active form tended to be identified in the tumors that coexpressed both MMP-9 and uPA. We concluded that coexpression of MMP-9 and uPA in tumor tissues might be a useful predictive factor for postoperative survival and hepatic metastasis. The following activation mechanism for proteinase might occur: uPA coexpressed with MMP-9 activated plasminogen, and plasmin activated proMMP-3, which was secreted depending upon inflammatory infiltration, and then MMP-3 activated proMMP-9, resulting in colorectal cancer progression and metastasis.
spellingShingle Inuzuka, K
Ogata, Y
Nagase, H
Shirouzu, K
Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
title Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
title_full Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
title_fullStr Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
title_full_unstemmed Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
title_short Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
title_sort significance of coexpression of urokinase type plasminogen activator and matrix metalloproteinase 3 stromelysin and 9 gelatinase b in colorectal carcinoma
work_keys_str_mv AT inuzukak significanceofcoexpressionofurokinasetypeplasminogenactivatorandmatrixmetalloproteinase3stromelysinand9gelatinasebincolorectalcarcinoma
AT ogatay significanceofcoexpressionofurokinasetypeplasminogenactivatorandmatrixmetalloproteinase3stromelysinand9gelatinasebincolorectalcarcinoma
AT nagaseh significanceofcoexpressionofurokinasetypeplasminogenactivatorandmatrixmetalloproteinase3stromelysinand9gelatinasebincolorectalcarcinoma
AT shirouzuk significanceofcoexpressionofurokinasetypeplasminogenactivatorandmatrixmetalloproteinase3stromelysinand9gelatinasebincolorectalcarcinoma